📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38a and BRD4. (2019)

First Author: Myers SM

Attributed to: Defining the role of ERK5 kinase and ERK5 transcriptional activities in cell migration and EMT using novel ERK5 inhibitors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejmech.2019.05.057

PubMed Identifier: 31212132

Publication URI: http://europepmc.org/abstract/MED/31212132

Type: Journal Article/Review

Volume: 178

Parent Publication: European journal of medicinal chemistry

ISSN: 0223-5234